Seruminstindia

Rediff.com » News » Seruminstindia

News for Seruminstindia

News

'Please be patient': Adar Poonawalla to nations waiting for Covishield

Adar Poonawalla, CEO of vaccine major Serum Institute of India, on Sunday urged other countries to be patient as they wait for the supplies of COVID-19 vaccine, Covishield, as the company has been......

DCGI approves Covovax for emergency use in 12-17 yrs age group

India's drug regulator has granted restricted emergency use authorisation to Serum Institute's COVID-19 vaccine Covovax for the 12-17 years age group subject to certain conditions. IMAGE: A......

'Decisive turning point': PM hails approval to vaccines

Hailing the approval given to two coronavirus vaccines as a 'decisive turning point' in the spirited fight against the pandemic, Prime Minister Narendra Modi said on Sunday that this will......

Serum cuts vaccine price for states to Rs 300/dose

Serum Institute of India -- the maker of the most used COVID-19 vaccine in the country -- on Wednesday announced a cut in price of the jab it plans to sell to states to Rs 300 per dose from the......

5 dead in Serum Institute fire; Covishield facility unaffected

Five men died after a fire broke out in a five-storeyed under-construction building in the Serum Institute of India's Manjri premises in Pune on Thursday, police said. IMAGE: Smoke billows......

Seruminstindia

News for Seruminstindia

'Please be patient': Adar Poonawalla to nations waiting for Covishield

DCGI approves Covovax for emergency use in 12-17 yrs age group

'Decisive turning point': PM hails approval to vaccines

Serum cuts vaccine price for states to Rs 300/dose

5 dead in Serum Institute fire; Covishield facility unaffected

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS